Woman Man | 18 years and more
- | Country :
- France
- | organs :
- Sein
- | Specialty :
- Thérapies Ciblées
Extract
A phase II trial of oral deforolimus (AP23573; MK-8669), an mTOR inhibitor, in combination with trastuzumab for patients with HER2-positive trastuzumab-refractory metastatic breast cancer.
Scientific Abstract
en cours d'intégration;